Background and Purpose-The mortality and morbidity after aneurysmal subarachnoid hemorrhage has improved because of better diagnosis, early treatment to secure the aneurysm, and better management of disease-specific complications. With these improvements in care, it is not clear if the previously identified independent predictors of a negative outcome have changed. The aim of this study was to identify the independent predictors of an unfavorable outcome (Glasgow Outcome Score 1, 2, and 3) in aneurysmal subarachnoid hemorrhage patients. Methods-Univariate and multivariate analysis of prospectively collected data on patients presenting with an aneurysmal subarachnoid hemorrhage was performed. Outcome was assessed at discharge. Data were collected from 14 centers in the United Kingdom over a period of 4 years (September 2011(September -2015 
A dvances in diagnostic and treatment strategies for aneurysmal subarachnoid hemorrhage (aSAH), through the introduction of computed tomography angiography with early detection of aneurysms, the use of nimodipine, specialist care for patients, and endovascular coiling of ruptured aneurysms, have substantially improved the outcomes of hospitalized patients. [1] [2] [3] [4] Despite these improvements, aSAH continues to exact a high economic and social cost. It remains a disease of relatively young people (median age of presentation, 52 years) and causes a loss of productive life-years similar to that of ischemic stroke. Economically, the costs to the United Kingdom economy (in direct and indirect costs) are estimated to be GBP 510 million annually. 5 Although several factors have been identified as important in predicting outcome, poor presentation grade, increasing age, preprotection aneurysm rebleeding, and delayed cerebral ischemia (DCI) are the only consistently identified independent predictors of a negative outcome in patients presenting with a aSAH. 4, [6] [7] [8] [9] [10] [11] [12] [13] Most of the studies used to determine prognostic factors to date are limited by either (1) being single-center series, (2) including a predominance of patients treated by open micro-neurosurgery, or (3) using a selected patient group randomized to clinical trials. Although most analyze and report on large prospective patient data sets, these data have been accumulated over a long period of time, and given the improvements in outcome seen over the last decade(s), we do not know whether the independent predictors of outcome reported are still valid. Equally, we do not know whether there are any new prognostic factors that can be modified to drive further improvements in care and outcome.
The aim of this study was to determine the independent predictors of a negative outcome in aSAH patients from a contemporary data set.
Materials and Methods

Study Design
This is a post hoc analysis of prospectively collected data on patients who presented with an aSAH to better understand predictors of outcome.
Setting
aSAH patient records were identified from the UK and Ireland SAH audit database (https://www.hope-academic.org.uk/ukSAH). This database was developed to prospectively collect anonymized data on consecutive SAH patients treated in UK neurosurgical centers. The database was established in September 2011, with 5 centers contributing initially. The number of centers increased over the next 4 years, with 14 of 32 (43%) centers from across the United Kingdom contributing data by September 2015. The aim of this database was to record typical features, process of care, and outcome of individuals with SAH.
Data Collection
Demographic data (age, center, sex, presence of ischemic heart disease, hypertension, and smoking status), severity of injury (World Federation of Neurological Surgeons [WFNS]), and aneurysm characteristics and treatments (aneurysm location, time to intervention, treatment modality, need for cerebrospinal fluid [CSF] diversion, complications [CSF infection, rebleed, DCI]) were collected.
14 Outcome was determined according to the Glasgow Outcome Scale (GOS) at discharge. Discharge destination and length of stay were also recorded. All data submitted were subject to the following preagreed definitions in accordance with the standard operating policy of the database. CSF infection was defined as definite (if microbiologically proven) or probable (clinical signs and symptoms of CSF sepsis leading to clinician starting antimicrobial treatment). Presence of hypertension and ischemic heart disease was determined from the past medical history provided by the patient or relatives on admission. WFNS grade was recorded at the time of referral to the neurosurgical center. DCI was defined as: 15 GOS was dichotomized into favorable outcome (GOS score 4 and 5) and unfavorable outcome (GOS score 1-3). 16 Data entry, including outcome assessment at discharge, was done by neurovascular clinical nurse specialists.
Participants
For the purpose of this study, only patients presenting with an aSAH were analyzed.
Statistical Methods
Statistical analysis was performed using Wizard 1.8.17. Univariate analysis was performed for all categories to determine significant differences between patients making a favorable recovery and those not. Categorical variables were assessed using the Chi-squared test.
Distribution of continuous data was tested using the Shapiro-Wilk test. The t test was used for normally distributed data and MannWhitney or Kruskall-Wallis for data that was not normally distributed. Case mix adjustment using binary logistic regression was then performed to determine the odds of achieving an unfavorable outcome or being discharged home with variables identified to be significant on univariate analysis. Significance was defined as P<0.05. Only available data were analyzed.
Ethical approval was not sought because this analysis was a secondary use of information previously collected in the course of normal care. In this no patients or service users were identifiable to the research team carrying out the analysis. All research were performed according to the principles of the Declaration of Helsinki.
Results
Of 4634 patients recorded on the UK and Ireland SAH audit database, 1029 patients did not have an aneurysm recorded as a cause for the SAH. In 264 cases, either there was no record of the underlying cause or the cause was classified as nonaneurysmal. Three thousand three hundred and forty-one patients were recorded to have an intracranial aneurysm and were eligible for analysis. Overall, 5% of data were missing. Low rates of data were missing for WFNS grade (1.2%), rebleed (0.1%), CSF diversion (1.5%), DCI (0.1%), GOS (4.0%), and discharge destination (3.0%).
The median age at presentation of the cohort was 55 years, and the majority of patients were female. Although most patients presented in good grade, almost a quarter of patients (n=854; 24.9%) presented in poor grade. Most patients had anterior circulation aneurysms, 3 quarters of patients were treated by endovascular coiling, and over one third (n=1058; 34.2%) required some form of CSF diversion procedure. CSF diversion was in the form of an external ventricular drain in the majority (n=809/1058; 83%; Table 1 ).
The majority of patients (n=2385; 71.4%) had made a favorable recovery discharge, and most (n=1836; 54.4%) were discharged home directly from the neurosciences center after a median hospital stay of 15 days (Table 2) .
Patients who had an unfavorable outcome at discharge were significantly older, more often presented in poor clinical grade, were more likely to be smokers, and have a history of hypertension or ischemic heart disease at presentation. The incidence of rebleed, need for CSF diversion, and CSF infection were significantly higher in patients with an unfavorable outcome ( Table 3) .
The time interval between admission and securing of aneurysm was not significantly longer for patients in the favorable group compared with patients in the unfavorable group.
Significant factors from the univariate analysis were entered into a multiple regression model to determine the independent predictors of an unfavorable outcome at discharge and the adjusted odds of getting home.
Previously well-accepted independent predictors of negative outcome, such as age, WFNS grade, preoperative rebleed, and lack of treatment were confirmed in this cohort (Table 4) . Increasing age, worse grade at presentation, preoperative rebleed, and no treatment were also factors that significantly reduced the odds of being discharged home.
The model also identified that patients who had a CSF diversion procedure were 3.25-fold more likely to have an
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November 2017 unfavorable outcome independent of age, WFNS grade, preoperative rebleed, and no treatment. The adjusted odds of being discharged home were also significantly lower in patients who had a CSF diversion procedure. The adjusted odds of discharge home were also significantly lower (odds ratio, 0.31; confidence interval, 0.15-0.70; P=0.005) for patients who had a definite CSF infection (Table 5) .
Discussion
We have shown that increasing age, WFNS grade at presentation, preoperative rebleed, and DCI remain independent predictors of an unfavorable outcome in patients presenting with aSAH. We have also observed that the need for CSF diversion is associated with 3.25-fold adjusted odds of an unfavorable outcome at discharge. These data are important because understanding why the need for CSF diversion was associated with a risk of a poor outcome may drive further improvements in outcome after aSAH, particularly, as factors such as age or injury severity cannot be modified. Definite CSF infection is an independent negative predictor of being discharged home and may be a cause of poor outcomes associated with CSF diversion.
Bias in studies on prognostic factors can be categorized into those related to study participation, study attrition, prognostic factor and outcome assessment, confounding factors, and statistical analysis.
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Study Participation
Our data represent the largest contemporary aSAH patient database. The purpose of the database is explicit, ensuring that the population studied is representative of the target population. The patient episodes have been accumulated over a short space of time from multiple regional centers in the United Kingdom. It is data reflective of current clinical practice where about one quarter of patients are in poor grade at presentation, and most patients are treated early by endovascular coiling. Our study may be limited in that the data are applicable to patients transferred to regional (tertiary) neurosurgical centers only. A national audit has previously shown that ≈10% of SAH patients in the United Kingdom were not admitted to tertiary centers for treatment to secure the aneurysm because of clinical futility. This practice was judged to be appropriate by a multidisciplinary panel of national experts. 18 This pragmatic approach is used by many centers around the world, and therefore, these results remain widely applicable. Our data may also be limited because data from each center has not been independently validated, and there is no case ascertainment check.
We have compared where possible data from our database with Hospital Episode Statistics data. For the 6 English centers that have consistently reported data for >1 year, there has been no significant difference between the numbers of patients identified by Hospital Episode Statistics data using International Classification of Diseases codes 600-609 (801 patients according to Hospital Episode Statistics data versus 721 patients according to submitted data).
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Study Attrition
This is a study of consecutive patients collected as part of a process to help with benchmarking between centers and as part of clinical audit, and therefore, there is no attrition of patient data. Equally and because outcome data are collected at discharge, there are few (<5%) outcome data missing.
Prognostic Factor and Outcome Measurement
Data including outcomes are collected by clinical nurse specialists who are well versed with the SAH patient journey and determined by preset definitions minimizing incorrect data entry. Our data are also limited in that outcomes are recorded at discharge, while most clinical trials report outcomes at 3 months.
Confounding Factors
All observational studies are at risk of confounding factors. We have previously discussed bias associated with not being able to guarantee case ascertainment. We have tried to minimize bias by analyzing and performing a univariate analysis and then a multivariate logistic regression analysis of all factors that can impact on outcome that were collected as part of our registry rather than looking at specific factors alone. There may of course be factors that are not recorded in this registry, as well as unknown factors that could introduce bias, and therefore, our results should be interpreted in this context. 
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Statistical Analysis
The only selective analysis conducted is that although the database records data for all patients with SAH, the analysis is conducted only on patients with aSAH, which are a distinct and well-defined entity. All other data collected was included in the analysis. Preoperative rebleeding is a well-accepted predictor of outcome in many studies and remains a challenge in this contemporary real-world population of aSAH patients. 20 Early treatment of ruptured aneurysm is now considered the norm to reduce rebleeding, and this is reflected in this series where the median time to treat was 1 day. Ultra-early treatment strategies have been proposed by several aSAH treating specialists, although this has not been shown to be any better than a more pragmatic treat as early as possible approach in some studies. 21, 22 In trying to prevent preoperative rebleeding, it remains important to understand the population in which it occurs. Although critical to avoid rehemorrhage in good-grade patients, rebleed in poor-grade patients may be the result of a purposeful treatment strategy driven by the clinical presentation and acute pathophysiological changes. Equally, it has been shown in contemporary studies that most rebleeds occur within 6 hours of aneurysm rupture, and given that in the majority of healthcare systems patients require transferring to specialist centers even if practical to deliver, an ultraearly intervention approach may not be enough. 23 Therefore, to address this issue, pharmacological strategies to minimize rebleeding are probably best, and currently this approach is being trialed in a phase III study. 24 DCI is another well-accepted factor that contributes to poor outcome. 10, 25 Many trials have tested a wide range of medications to attenuate the ill effects of DCI, but currently only Nimodipine has been shown to be effective in a phase III trial. 26 Over time, a clinical definition of the syndrome of secondary deterioration has been agreed, and there is now better understanding of the pathophysiology of secondary deterioration, which may help in minimizing the ill effects of DCI. 27, 28 Given the challenges of minimizing the negative effects of rebleeding and DCI alluded to earlier, understanding the reasons for the increased odds of a poor outcome in patients requiring a CSF diversion may lead to more immediate improvements in outcome in aSAH patients. Although our data are not detailed enough to investigate why CSF diversion negatively affects outcome, it does suggest that CSF infection may be a contributory factor because confirmed CSF infection was significantly associated with odds of being discharged home.
There are several other reasons why CSF diversion may be associated with poor outcome. This may be a direct result of aSAH-related hydrocephalus causing raised intracranial pressure. Equally, it may be because of iatrogenic injury from drain malplacement, which reportedly occurs in 12% to 60%, 29, 30 rehemorrhage in 3.2% to 20%, 20, 23 and infection in ≤30%. 31 It is these secondary factors that need to be addressed with a view to minimizing harm and improving outcomes.
There is currently no national or international consensus to guide the decision making of CSF diversion in patients with an aSAH, and there is a wide range of practice reported. [32] [33] [34] Some authors have advocated an almost routine use of CSF drainage in patients who are WFNS grade ≤2. This is despite the recognition that many patients with hydrocephalus are not neurologically obtunded, and ≈50% of patients improve clinical grade without CSF diversion. 35, 36 This routine practice is most noticeable in poor-grade SAH patients where several centers have a blanket approach in using CSF diversion. 32 The argument for this approach is based on the observations that poor-grade patients can improve clinical grade after drainage of CSF and achieve outcomes similar to those present in good grade. 37 There is also anecdotal evidence that CSF diversion can improve cerebral oxygenation and reduce DCI. 38 However, not all patients, including those presenting in poor grade, have ventriculomegaly, and even those who do can improve clinical grade with time and without need for CSF diversion. In a series by Sasaki et al, 39 only 7 of 136 patients had overt radiological hydrocephalus, and 43 of 136 patients improved spontaneously. Where there is evidence of hydrocephalus from the outset, which Lu et al observed in 17.8% of patients, almost 30% recovered, one third remained stable, and only 37% of patients with radiological and clinical hydrocephalus required intervention. 37 In a consecutive series of 473 patients described by Hasan et al, 36 91 (19%) had hydrocephalus on the initial computed tomogram, and of these, conscious level was unimpaired in 25 (27%), and only 38 (8%) of all 473 patients deteriorated because of acute hydrocephalus. Of the 66 patients with acute hydrocephalus and impaired conscious level on admission, 26 (39%) spontaneously improved within 24 hours, and CSF diversion was required in only 32 (48%). Overall, CSF diversion was required in only one third of all patients with hydrocephalus and 7% of all 473 patients, which is much lower than the 34% of patients as described in this series. 36 Some of these discrepancies may be explained by the proportion of poor-grade patients treated but overall suggests that decisions should be made on a case-by-case basis rather than according to a set protocol even for poor-grade patients.
Summary/Conclusions
In a large contemporary series of aSAH, we have shown that potentially modifiable risk factors of preoperative rebleeding and DCI remain barriers to favorable outcomes. Understanding the reasons why patients requiring CSF diversion have higher adjusted odds of a poor outcome at discharge needs to be studied further.
